Knowing that many of the underlying immune mechanisms that are activated to fight tumor cells are also important in regulating immune responses, it comes as no surprise that HDAC inhibitors have been studied for their utility in treating chronic inflammatory disorders [119]. Here, HDAC9 is linked to neoplasm.